Clinical Trials
33 trialsMAGE-A4ᶜ¹º³²T for Multi-Tumor
USWM, LLC (dba US WorldMeds)
(NeoScorch HN)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
ORATOR2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Pembrolizumab in Combination With CRT for LA-SCCHN
Sanford Health
OutcomeH&N
Maastricht Radiation Oncology
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer
Providence Health & Services
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
Thomas Jefferson University
Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN
Dana-Farber Cancer Institute
PROMs
King Saud University
HNCs
Al-Maarif University College
PANTHEoN
Vanderbilt-Ingram Cancer Center
Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer
National Cancer Centre, Singapore
Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome
Wake Forest University Health Sciences
The Effect of Alpha Lipoic Acid on the Incidence and Severity of Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients
Ain Shams University
Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer
Case Comprehensive Cancer Center
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer
Shin Kong Wu Ho-Su Memorial Hospital
Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck
Emory University
Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)
University of Maryland, Baltimore
SUSPECT
The Netherlands Cancer Institute
Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer
Stanford University
Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma
Milton S. Hershey Medical Center
METAXIOM
Institut Cancerologie de l'Ouest
Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer
University of California, Irvine
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Masonic Cancer Center, University of Minnesota
Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy
Stanford University
Randomized Amifostine For SCCHN
Dana-Farber Cancer Institute
Open Label, Phase I ZD6474 Head and Neck Cancer Study
Sanofi
Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure
AHS Cancer Control Alberta
Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer
BioVex Limited
Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer
University of Kentucky
P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer
Shenzhen SiBiono GeneTech Co.,Ltd
Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer
Georgetown University